Health Condition 1: F40-F48- Anxiety, dissociative, stress-related, somatoform and other nonpsychotic mental disorders Health Condition 2: F01-F99- Mental, Behavioral and Neurodevelopmental disorders Health Condition 3: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Conditions
Interventions
Intervention1: ketofol-dexmedetomidine: In KFD -group 0.5 µg/kg dexmedetomidine (diluted to 10 ml with 0.9% saline) was infused intravenously over a period of 10 minutes and 10 minutes prior to the pr
Sponsors
Shri B M Patil Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Patients with ASA Grade I & II
Exclusion criteria
Exclusion criteria: Cardiovascular disease, Cerebrovascular disorder, Intracranial hypertension, Respiratory tract disease, Glaucoma, Presence of a pacemaker, History of seizures, ASA III –V physical status, History of allergy to the study drugs, Pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess seizure duration To evaluate an acceptable decrease in heart rate & blood pressure (systolic, diastolic) Timepoint: 5 & 10 & 30 minutes after the end of the seizure | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess agitation Timepoint: 24 hours;To assess depression , mania, psychosisTimepoint: 24 hours;To assess early post-M.E.C.T. complications. Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactCharishma Buddha
Shri B M Patil Medical College, Vijayapura
Outcome results
None listed